Shukra Pharmaceuticals (BOM:524632) Days Sales Outstanding : 136.55 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Shukra Pharmaceuticals Days Sales Outstanding?

Shukra Pharmaceuticals's average Accounts Receivable for the three months ended in Dec. 2023 was ₹283 Mil. Shukra Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was ₹189 Mil. Hence, Shukra Pharmaceuticals's Days Sales Outstanding for the three months ended in Dec. 2023 was 136.55.

The historical rank and industry rank for Shukra Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

BOM:524632' s Days Sales Outstanding Range Over the Past 10 Years
Min: 55.31 Med: 137.01 Max: 288.5
Current: 68.08

During the past 13 years, Shukra Pharmaceuticals's highest Days Sales Outstanding was 288.50. The lowest was 55.31. And the median was 137.01.

BOM:524632's Days Sales Outstanding is ranked better than
53.81% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs BOM:524632: 68.08

Shukra Pharmaceuticals's Days Sales Outstanding increased from Dec. 2022 (121.37) to Dec. 2023 (136.55).

Shukra Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Shukra Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shukra Pharmaceuticals Days Sales Outstanding Chart

Shukra Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

266.77

204.86

288.50

152.77

116.60

Shukra Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															121.37	59.56	136.63	104.69	136.55

Competitive Comparison of Shukra Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Shukra Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shukra Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shukra Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Shukra Pharmaceuticals's Days Sales Outstanding falls into.

Shukra Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Shukra Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (74.008	+	301.867)	/	2 )	/	588.336	*	365
=	187.9375					/	588.336	*	365
=	116.60

Shukra Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (282.68	+	0)	/	1 )	/	188.906	*	365 / 4
=	282.68					/	188.906	*	365 / 4
=	136.55

Shukra Pharmaceuticals (BOM:524632) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Shukra Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Shukra Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Shukra Pharmaceuticals (BOM:524632) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shukra Pharmaceuticals Ltd (BOM:524632) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

Judges Bunglow Road, Bodakdev, 3rd Floor, Veer House, Opposite WIAA Office, Ahmedabad, GJ, IND, 380054

Website

https://www.shukrapharmaceuticals.com

Shukra Pharmaceuticals Ltd is engaged in the business of manufacturing and trading pharmaceutical products. The company markets its products in India and international markets. The company has two operating segments; pharmaceutical and Laboratory. Its product portfolio includes antibiotics, antibiotics, quinolones, macrolides, anti-bacterial, anti-fungal, anti-malarial, anti-viral, antiprotozoal, anti-anthelmintic, anti-depressant, anti-manic, anti-emetic, beta-blockers, analgesic, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergic, corticosteroids, hyper and hypoglycemic, and others. It exports its products to Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen.

Shukra Pharmaceuticals (BOM:524632) Headlines

No Headlines